Donoghue Forlines’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-25,177
Closed -$2.14M 130
2025
Q3
$2.14M Buy
+25,177
New +$1.99M 0.66% 42
2023
Q3
Sell
-5,245
Closed -$327K 256
2023
Q2
$327K Buy
5,245
+2,294
+78% +$153K 0.1% 215
2023
Q1
$213K Buy
+2,951
New +$231K 0.08% 206
2022
Q1
Sell
-9,369
Closed -$688K 283
2021
Q4
$688K Buy
9,369
+6
+0.1% +$404 0.12% 194
2021
Q3
$644K Buy
9,363
+2,480
+36% +$188K 0.12% 168
2021
Q2
$579K Buy
+6,883
New +$574K 0.11% 174
2019
Q2
Sell
-32,306
Closed -$2.78M 189
2019
Q1
$2.78M Buy
+32,306
New +$2.63M 0.28% 43

Other funds holding INCY

Donoghue Forlines's INCY Position: Q4 2025 in Review

Donoghue Forlines sold out of Incyte (INCY) in Q4 2025, closing a stake of 25,177 shares — an estimated $2.14M sold.

Donoghue Forlines first reported a position in INCY in Q1 2019 and held it in 7 quarters. The position peaked at $2.78M in Q1 2019. 822 funds tracked by Wall St. Rank hold INCY as of Q4 2025.

  • Donoghue Forlines reported no remaining Incyte position as of Q4 2025 after selling out during the quarter.
  • Donoghue Forlines sold 25,177 Incyte shares in Q4 2025, an estimated $2.14M.
  • Donoghue Forlines first reported a position in Incyte in Q1 2019 and held it in 7 quarters.
  • Donoghue Forlines's Incyte position peaked at $2.78M in Q1 2019.
  • 822 funds tracked by Wall St. Rank held Incyte as of Q4 2025.

Based on Donoghue Forlines's 13F filing for Q4 2025, filed 5 Feb 2026.